Novo Nordisk has very recently released their Fast Acting Insulin Aspart (FIASP) in Canada. This insulin has a much faster onset, peak, and clearance time than novolog insulin aspart. Studies have shown that postprandial Bg levels were normal even taking FIASP 20 minutes after eating.
FDA approval has been applied for but has not yet been granted. However, expectations are that the FDA approval should come relatively soon.